Partial spectral analysis of the hydroperoxide-induced chemiluminescence of the perfused lung  by Cadenas, Enrique et al.
Volume 111, number 2 FEBS LETTERS March 1980 
PARTIAL SPECTRAL ANALYSIS OF THE HYDROPEROXIDE-INDUCED 
CHEMILUMINESCENCE OF THE PERFUSED LUNG 
Enrique CADENAS, Ilan D. ARAD, Albert0 BOVERIS. Aron B. FISHER and Britton CHANCE 
Johnson Research Foundation and Deparment of Physiology, School of Medicine, G4, University of Pennsylvania, Philadelphia, 
PA I91 04. USA 
Received 20 December 1979 
1. Introduction 
Evaluation of the oxidative stress in the intact 
organ can be approached with different experimental 
techniques such as glutathione release [l-3], hydro- 
carbons expiration [4-61 and chemiluminescence. 
Low level chemiluminescence of the intact organ 
permits an assessment of the oxidative stress that does 
not involve an invasion or destruction of the tissue 
and establishes a great advantage over the thiobarbi- 
turic acid assay (malonaldehyde) [7] as indicated [8]. 
The detection of chemiluminescence from the liver 
in situ was reported in 1961 [9] and therefrom an 
extraordinary development has been made in chemi- 
luminescence applied to organs, organelles and model 
systems. 
A low level chemiluminescence from the in vivo 
and in vitro liver was reported [ 10,l 11, rekindling 
great interest in the subject. Light emission from 
tissue homogenates [ 12,131, mitochondria [ 14,151, 
and microsomal fractions [ 16,171. as well as model 
systems [ 18,191 helps to build up a possible mecha- 
nism for the chemiluminescence of the intact organ 
that per se presents a great difficulty. 
We have reported on the hydroperoxide-induced 
chemiluminescence of the perfused lung [20] 
emphasizing the relationship between chemilumines- 
cence and pulmonary edema, as well as the effect of 
paraquat on light emission. Here, we summarize the 
dual effect on lung chemiluminescence induced by 
either H202 or t-butyl hydroperoxide and offer a 
first approach to the nature of light emission by means 
of a partial spectral analysis of the lung chemi- 
luminescence. 
2. Materials and methods 
2 .l . Chemicals 
t-Butyl hydroperoxide (t-BOOH) was obtained 
from Aldrich Chemical Co. (Milwaukee, WI) and 
HzOz from J. T. Baker, Chem. Co. (Phillipsburg, NJ). 
2.2. Lung perfusion 
The lungs of Sprague-Dawley male rats (Charles 
River Breeding Labs., Inc., Wilmington, MA) (300- 
350 g body wt) were isolated by the technique in 
[ 2 11. Lungs were perfused at a rate of 10 ml/min 
with a Krebs-Ringer phosphate buffer (pH 7.3-7.4) 
that was kept at 37’C. The perfusate was not 
recirculated. Ventilation and perfusion pressures were 
monitored continuously with pressure transducers 
(Statham Instr. 123 FD) and recorded with an oscil- 
lograph (MFE Corp., Salem, NH). t-Butyl hydro- 
peroxide or hydrogen peroxide was infused with a 
syringe pump, model 341, (Sage Instr., Orion Labs., 
Cambridge, MA) into a cannula situated in the inflow 
of the pulmonary artery. The rate of infusion was 
-0.3 ml/min. 
2.3. Photon counting 
Chemiluminescence was measured in a photon 
counter as in [ 10,l I] using an EMI 9658 photo- 
multiplier responsive in the range 300-900 nm 
connected to a photon counter system [ 111. The 
perfused lung was placed in a special lighttight box as 
close as possible to the end of the light guide. Kodak 
wratten filters (Eastman Kodak Co., Rochester, NY) 
with selective spectral transmittance in the visible or 
red regions were placed in front of the phototube in 
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order to obtain a partial spectral distribution of the 
light observed. The estimated spectra of the hydro- 
peroxide-induced chemiluminescence of the lung 
were calculated by superimposing the relative chemi- 
luminescence yields (ratio of counts/s with a filter to 
counts/s without a filter), corrected for the photo- 
multiplier efficiency, and read by a densitometer. 
3. Results 
3.1. t-Butyl h>Jdroperoxide- and/or H202-induced 
chemiluminescence of the lung 
In these experimental conditions, and with a red- 
sensitive EM1 phototube, a background level of about 
350 counts/s was observed; the darkcurrent was -50 
counts/s. A total chemiluminescence yield of 745 + 60 
counts/s was observed in the perfused lung upon 
infusion with HzOz and of 1600 + 200 counts/s upon 
infusion with t-butyl hydroperoxide. 
Fig.1 shows the chemiluminescence of the perfused 
lung upon the successive infusion of both hydro- 
peroxides. The light emission signal began immediately 
after the starting of the infusion of H,02, reached its 
maximum in -1.5 min, and kept constant at its maxi- 
mum level as long as the infusion of H,Oz was main- 
tained. tight emission decayed slowly to the back- 
ground upon withdrawal of the HzO,. A successive infu- 
sion of the tertiary hydroperoxide, t-butyl hydroper- 
oxide, produced a different kinetic pattern, increasing 
the total chemiluminescence yield, but with a slower 
rate than that of the HzO,enhanced chemilumines- 
jmd H,O,/mln ,mol t-800Hlmin 
0 1 168 1 0 168 0 
2mn 
-it-- 
Fig.1. Lung chemiluminescence successively induced by 
H,O, and t-butyl hydroperoxide (t-BOOH). The infusion 
rate of the peroxides was kept constant as indicated in the 
upper ordinate. Start or withdrawal of the peroxide infusion 
is indicated by 0 in the ordinate. The rate of lung perfusion 
was maintained at 10.5 ml/min. Other assay conditions as in 
section 2. 
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Fig.2. Lung chemiluminescence simultaneously induced by 
H,O, and t-butyl hydroperoxide. Assay conditions as 
described in fig.1. When the constant level of chemilumines- 
cence of the lung induced by H,O, was achieved, t-butyl 
hydroperoxide infusion was started. 
cence; a tendency to saturation was observed only 
after 3 min infusion with t-butyl hydroperoxide. 
In each experiment, the lungs showed a higher rate 
of chemiluminescence and a lower chemiluminescence 
yield with H,Oz. 
The effect of the simultaneous addition of both 
peroxides on the perfused lung chemiluminescence is 
shown in fig.2. The infusion of t-butyl hydroperoxide 
was started when the constant level of light emission 
induced by the HzO, infusion was achieved. Photo- 
emission rose over the HzO, constant level, showing 
once more a different kinetic pattern of chemi- 
luminescence. When the infusion of both peroxides 
was halted, the signal decayed slowly and approached 
the background in -10-15 min. 
3.2. Partial spectral distribution of lung chemilu- 
minescence 
By means of an interference Wedge filter. in a 
model system formed by cytochrome c and hydroper- 
oxide, we have obtained maximal emission of 
chemiluminescence at 662 nm and 590 nm with t- 
butyl hydroperoxide and hydrogen peroxide, respec- 
tively (E. C. unpublished). The use of an interference 
filter in organ chemiluminescence is restricted by the 
low chemiluminescence yield of the system; therefore 
it was replaced by gelatin filters (Kodak wratten 
filters) that give a wide, though not exact, approach 
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to the wavelength of the light emission observed. 
The t-butyl hydroperoxideinduced chemilumines- 
cence of the perfused lung indicated a chief compo- 
sition of red light-emitting species with little con- 
tribution of green light-emitting species. Fig.3 shows 
the light emission of the perfused lung when the 
Wratten filters were placed in front of the photo- 
multiplier; maximal light emission was observed with 
red filters (no. 29,70) with spectral transmittance 
beyond 600 and 650 nm (fig.3b,c), and almost 
negligible light emission was detected beyond 730 nm 
with a dark red filter (no. 88A) (fig.3d); a photo- 
emissive component with a wavelength between 400 
and 600 nm (green filter no. 64) was also small com- 
pared with the red species contribution. Fig.3B sums 
up the spectral distribution of the t-butyl hydroper- 
oxide-induced chemiluminescence of the lung and 
shows that the major contribution is done by species 
emitting between 650 and 720 nm, with a small band 
between 600 and 650 nm. 
On the other hand, the HpOz-enhanced lung chemi- 
luminescence showed some differences from the spec- 
tral distribution of the t-butyl hydroperoxide-induced 
chemiluminescence that are shown in fig.4. Fig.4A 
indicates the direct light emission signal obtained 
with the superposition of different filters. At variance 
with the t-butyl hydroperoxide-induced chemi- 
luminescence, components beyond 650 nm (red filter 
70) are of smaller importance (fig.4e), whereas 
maximal light emission is obtained with filters with 
spectral transmittance beyond 520 and 600 nm 
(filters 16,29) (fig.4b and c, respectively). Further- 
more, the HzOz-induced chemiluminescence of the 
lung, more than the t-butyl-enhanced chemilumines- 
cence, is associated with components emitting between 
400 and 600 nm (filter 64; fig.4d). FigAB shows that 
the lung chemiluminescence obtained upon infusion 
of HzOz is increasingly associated with components 
that have an emission wavelength from 520 toward 
650 nm. 
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Fig.3. Partial spectral analysis of t-butyl hydroperoxide-induced chemiluminescence of the lung. (A) Assay conditions as in fig.1. 
Kodak wratten filters were placed in front of the EMI phototube: (a) control; (b) filter 29; (c) filter 70; (d) filter 64; (e) filter 
88A. Explanations in the text. (B) Diagram illustrating the relative spectral distribution of t-butyl hydroperoxide-induced light 
emission of the lung obtained from the data of (A). 
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Fig.4. Partial spectral analysis of H,O,-induced chemiluminescence of the lung. (A) Assay conditions as in fig.3 and further 
explanations in the text. Trace: (a) control; (b) filter 16; (c) filter 29, (d) filter 64; (e) filter 70. (B) Diagram illustrating the 
relative spectral distribution of the H,O,-induced photoemission of the lung obtained from the data of (A). 
4. Discussion 
The different kinetic pattern of chemiluminescence 
of the lung obtained with the successive infusion of 
HzOz and t-butyl hydroperoxide, along with the t- 
butyl hydroperoxideenhancement of chemilumines- 
cence over the already saturated light emission caused 
by Hz02, suggest he participation of different 
enzymatic activities for the metabolism of each per- 
oxide. Hydroperoxides, either added or formed 
through a biologically iron-catalysed reaction. provide 
a chemiluminescence model reaction related to lipid 
peroxidation comprising certain enzymic activities 
such as glutathione peroxidase. Tertiary hydroper- 
oxides, such as t-butyl hydroperoxide, are commonly 
used when measuring the glutathione peroxidase par- 
ticipation in oxidative metabolism in order to avoid 
any possible involvement of catalase [22]. Apparently, 
the different light emission signals reported here 
might be due to activities of catalase and glutathione 
peroxidase for HzOz and t-butyl hydroperoxide. We 
want to hint at this phenomenon, but do realize the 
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necessity of obtaining further evidence such as might 
be provided by the effects of lungs of rats fed a 
selenium-deficient diet on the hydroperoxide-induced 
chemiluminescence. 
Most of the evidence on the nature of organ light 
emission will rest on data obtained from organelles 
and model systems, where a mechanism is easier to 
elucidate; this report, however, deals with the fact of 
a recognizable wavelength band, which permits cer- 
tain approaches to the nature of the photoemission 
observed. Basically, singlet molecular oxygen is 
involved with chemiluminescence directly or indi- 
rectly. Its generation along with its participation in 
the light observed is stated in scheme 1. The two 
bands observed in the t-butyl hydroperoxide-stim- 
ulated chemilummescence of the lung cover the 634 
and 703 nm peaks of the singlet oxygen dimol emis- 
sion when decaying to the ground state [23,24]; on 
the other hand, the participation of different light- 
emitting species, such as excited carbonyl groups, 
through a dioxetane mechanism [25]. seems more 
feasible in the HzOz-induced light emission of the 
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A GENERATION OF ‘4 
Termination reactions of peroxy radicals 
I) Primary and secondary peroxy radicals 
ROO’+ ROD.- ‘O*+ ROH + RO 
2) Tertiary peroxy radicals 
tBO0’ + tBO0’ - ‘4 + tBCOBt 
I6 EMISSION OF LIGHT 
3) Monomol emission (I260,1430 nm) 
‘02 --&a + hu 
4) Dimol emission (634,703 nm) 
2’0, - 230, + hv 
5) Dioxetane mechanism (350 -48Onm) 
a) ‘0, + = - -j--j- ->c=o+ >czO$: 
o-o 
b) >C=O‘::->C=O + hv 
Scheme 1
lung, since it shows a stronger involvement of green 
light~n~itting species. 
It is worth noting that, because of the heteroge- 
neity of the system studied, the wavelengths of the 
singlet oxygen dimol emission could be shifted; 
systems which are known to produce singlet oxygen, 
such as the HC1O/NHa/HzOa system, were reported 
to have their spectral distribution of chemilumines- 
cence shifted toward shorter wavelengths in the pres- 
ence of certain amino acids [26]; moreover, the 
myeloperoxidase system and phagocytosing poly- 
morphonuclear leukocytes show a maximal chemi- 
luminescence emission at -580 nm 1271 in spite of 
the strong evidence supporting their generation of 
singlet oxygen [28]. 
At present, the utilization, in the perfused 
lung, of either quenchers of singlet oxygen, such as 
p-carotene 1291 or enhancers of the singlet oxygen 
dimol emission, such as 1,4-diazabicyclo- [2,2,2] - 
octane [30] is very limited. 
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